Marc André, UCL

 

Willem Daneels, UZ Gent

 

Michel Delforge, UZ Leuven
Nikki Granacher, ZNA

 

Bert Heyrman, ZNA
Ann Janssens, UZ Leuven


 Prof. Ann Janssens is Head of Clinics in the Department of Hematology at Leuven University Hospital, Leuven, Belgium. She obtained her medical degree from the University of Ghent, before specializing there in hematology. In vitro apoptosis and clonal evolution in chronic lymphocytic leukemia (CLL) was the title of her doctoral thesis.

Prof. Janssens has a special interest in CLL and other indolent lymphomas and also in immune thrombocytopenias (ITP). She acts as a co-ordinator for Phase I–IV clinical studies relating to CLL-low grade lymphomas and ITP. She has published in several peer-reviewed journals. She is a member of the editorial board of The Belgian Journal of Hematology. Since 2019 she is the President of the Belgian Hematological Society.
Catherine Lambert, UCL

 

Stef Meers, AZ Klina

 

Nathalie Meuleman, Institut Jules Bordet

 

Gilles Salles, Memorial Sloan Kettering Cancer Center, NYC
Bram Siot, UZ Leuven

 

Marie Christiane Vekemans, UCL